Sectors
ICCC
ImmuCell Corporation
9.79
2 x 7.06
2 x 12.78
bid
ask
-
0.15
1.51%
2 @ 07:30 PM
9.79 +0.00 (0.00%)
| Ytd | 59.19% | |
| 1y | 52.97% |
9.77
day range
10.00
4.52
52 week range
12.10
| Open | 9.86 | Prev Close | 9.94 | Low | 9.77 | High | 10.00 | Mkt Cap | 88.91M |
| Vol | 20.13K | Avg Vol | 29.32K | EPS | 0.07 | P/E | 139.86 | Forward P/E | -42.82 |
| Beta | 0.57 | Short Ratio | 0.23 | Inst. Own | 14.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 10.56 | 200-d Avg | 7.91 | 1yr Est | 14.00 |
| Income Statement | |||
| Total Revenue | 7.19M | ||
| Revenues (USD) | 7.19M | ||
| Cost of Revenue | 4.75M | ||
| Gross Profit | 2.44M | ||
| Operating Expenses | 502.29K | ||
| Research and Development Expense | 119.65K | ||
| Selling, General and Administrative Expense | 2.38M | ||
| Operating Income | 1.93M | ||
| Income Tax Expense | 45.95K | ||
| Net Income | 1.83M | ||
| Net Income Common Stock | 1.83M | ||
| Net Income Common Stock (USD) | 1.83M | ||
| Consolidated Income | 1.83M | ||
| Earnings per Basic Share | 0.20 | ||
| Earnings per Basic Share (USD) | 0.20 | ||
| Earnings per Diluted Share | 0.20 | ||
| Earning Before Interest & Taxes (EBIT) | 1.88M | ||
| Earning Before Interest & Taxes (USD) | 1.88M | ||
| Weighted Average Shares | 9.06M | ||
| Weighted Average Shares Diluted | 9.19M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.86M | ||
| Cash and Equivalents (USD) | 8.86M | ||
| Trade and Non-Trade Receivables | 2.90M | ||
| Current Assets | 21.08M | ||
| Property, Plant & Equipment Net | 25.42M | ||
| Total Assets | 46.63M | ||
| Debt Current | 1.63M | ||
| Total Debt | 12.45M | ||
| Current Liabilities | 4.44M | ||
| Debt Non-Current | 10.82M | ||
| Total Liabilities | 15.26M | ||
| Accumulated Retained Earnings (Deficit) | -11.43M | ||
| Shareholders Equity | 31.37M | ||
| Shareholders Equity (USD) | 31.37M | ||
| Assets Non-Current | 25.55M | ||
| Total Debt (USD) | 12.45M | ||
| Goodwill and Intangible Assets | 95.56K | ||
| Inventory | 9.08M | ||
| Liabilities Non-Current | 10.82M | ||
| Trade and Non-Trade Payables | 2.81M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 470.62K | ||
| Net Cash Flow from Financing | -237.56K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.05M | ||
| Capital Expenditure | -733.94K | ||
| Issuance (Purchase) of Equity Shares | 164.97K | ||
| Issuance (Repayment) of Debt Securities | -402.54K | ||
| Net Cash Flow from Investing | -733.94K | ||
| Net Cash Flow from Operations | 3.02M | ||
| Share Based Compensation | 239.87K | ||